-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Plenary Session: Performance by Dr. Rizzo Rouce

Symposia: ASH-a-Palooza Program: Trainee Activities and Services
Friday, December 6, 2024: 12:45 PM-12:50 PM
Main Stage (Gaslamp Quarter)
Speakers:
Rayne Rouce, MD, Clinical Care Center-Texas Children's Hospital and Hetty E. Carraway, MD, MBA, Cleveland Clinic Taussig Cancer Institute
Disclosures:
Carraway: Novartis: Membership on an entity's Board of Directors or advisory committees; Abbvie: Membership on an entity's Board of Directors or advisory committees; Jazz: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Daiichi: Membership on an entity's Board of Directors or advisory committees; Celgene: Research Funding; Stemline: Membership on an entity's Board of Directors or advisory committees; BMS: Membership on an entity's Board of Directors or advisory committees; Servier: Membership on an entity's Board of Directors or advisory committees.

Special rap performance pediatric hematologist Dr. Rayne "Rizzo" Rouce followed by a speech from the ASH Committee on Training Chair, Dr. Hetty Carraway.